Apheon completed the acquisition of a majority stake in Diagnostica Longwood.

Apheon, a mid-market private equity investor, completed the acquisition of a majority stake in Diagnostica Longwood, a Spanish provider of high-value-added in-vitro diagnostics (IVD) equipment, solutions, and services for hospitals and laboratories. Financial terms were not disclosed. “In Apheon, I believe we found the best partner to further unlock our ambitions to grow our group and presence,” Antonio Raichs, Diagnostica Longwood Founder and Chairman.